Free Access
Epidemiology and Natural History of Benign Prostatic Hyperplasia
Taiji Tsukamoto,
Naoya Masumori,
Corresponding Author
Taiji Tsukamoto
Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan
*Department of Urology, Sapporo Medical University School of Medicine, Sapporo 060, Japan.Search for more papers by this authorNaoya Masumori
Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan
Search for more papers by this authorTaiji Tsukamoto,
Naoya Masumori,
Corresponding Author
Taiji Tsukamoto
Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan
*Department of Urology, Sapporo Medical University School of Medicine, Sapporo 060, Japan.Search for more papers by this authorNaoya Masumori
Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan
Search for more papers by this author
References
- 1 Walsh PC. Benign prostatic hyperplasia. In: PC Walsh, AB Retik, TA Stamey ED Vaughan, (eds) Campbell's urology. 6th ed. Vol. 1. Philadelphia : WB Saunders, 1992: 1009–1027.
- 2 Imai K, Kurokawa K, Sekihara T, Suzuki T, Yamanaka H, Takahashi H, Mashimo T, Takahashi O, Kitaura H, Saruki K, Makino T, Kurihara H. Symptoms and signs of benign prostatic hypertrophy. Acta Urol Jpn 1993; 39: 15–22.
- 3 Guess HA. Benign prostatic hyperplasia: antecedents and natural history. Epidemiol Rev 1992; 14: 131–153.
- 4 Benign Prostatic Hyperplasia Guideline Panel. Benign prostatic hyperplasia: diagnosis and treatment. Rockville, Maryland: U.S. Department of Health and Human Services, 1994: AHCPR publication no–0582. (Clinical Practice Guideline; no 8.): 67–75.
- 5 Wasson JH, Reda DJ, Bruskewitz RC, Elison J, Keller AM Henderson WG, for the Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. A comparison of transurethral surgery with watchful-waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med 1995; 332: 75–79.
- 6 Bostwick DG. Neoplasms of the prostate. In: DG Bostwick, JN Eble, (eds) Urologic surgical pathology. St. Louis : Mosby, 1997: 343–422.
- 7 Price H, McNeal JE, Stamey TA. Evolving patterns of tissue composition in benign prostatic hyperplasia as a function of specimen size. Hum Pathol 1990; 21: 578–585.
- 8 Lepor H, Shapiro E, Wang B, Liang YC. Comparison of the cellular composition of benign prostatic hyperplasia in Chinese and Caucasian-American men. Urology 1996; 47: 38–42.
- 9 Shapiro E, Becich MJ, Hartanto V, Lepor H. The relative proportion of stroma and epithelial hyperplasia is related to development of symptomatic benign prostatic hyperplasia. J Urol 1992; 147: 1293–1297.
- 10 Furuya S, Ogura H, Tanaka Y, Masumori N, Tsukamoto T. Morphological study on smooth muscle cells of benign prostatic hyperplasia. Jpn J Urol 1996; 87: 576 (abstr, in Japanese).
- 11 Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia. J Urol 1984; 132: 474–479.
- 12
Issacs JT,
Coffey DS.
Etiology and disease process of benign prostatic hyperplasia.
Prostate
1989; 16(suppl 2): 33–50.
10.1002/pros.2990150506 Google Scholar
- 13 Bostwick DG, Balcells FS, Cooner WH, Denis L, Gu F-L, Jones GW, Khoury S, Kotake T, De Matteis A, Pagano F, Scardino PT, Murphy GP. Benign prostatic hyperplasia (BPH) and cancer of the prostate. In: ATK Cockett, Y Aso, C Chatelan, L Denis, K Griffiths, S Khoury, GP Murphy, (eds) Proceedings of the first International Consultation on Benign Prostatic Hyperplasia. Paris : Scientific Communication International, 1991: 139–159.
- 14 Karube K. Study on latent carcinoma of the prostate in the Japanese based on necropsy material. Tohoku J Exp Med 1961; 74: 265–285.
- 15 Kato T. Histological study on hyperplasia of the prostate with special reference to histogenesis of nodule. Jpn J Urol 1967; 58: 469–483.
- 16 Akimoto M. On the morphological alteration of the prostate. II. A correlative histopathological study of the latent and manifested nodular hyperplasia of the prostate gland and senile changes of the testis. Jpn J Urol 1967; 58: 814–841 (in Japanese).
- 17 Wada T, Furusato M. Chronological changes of histology in benign prostatic hyperplasia. In: Prostate Research Foundation (ed) Diagnostic manual for benign prostatic hyperplasia. Tokyo : Kanahara, 1990: 54–61 (in Japanese).
- 18 Guess AH. Population-based studies of benign prostatic hyperplasia. In: R Kirby, J McConnel, J Fitzpatrick, C Roehrborn, P Boyle, (eds) Textbook of benign prostatic hyperplasia. Oxford : ISIS Medical Media, 1996: 117–124.
- 19
Lytton B.
Interracial incidence of benign prostatic hypertrophy. In: F Hinman, (ed)
Benign prostatic hypertrophy.
New York
: Springer-Verlag, 1983: 22–26.
10.1007/978-1-4612-5476-8_3 Google Scholar
- 20 Arrighi HM, Metter EJ, Guess AH, Fozzard JL. Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Studying of Aging. Urology 1991; 38(suppl): 4–8.
- 21
Tsukamoto T,
Kumamoto Y,
Umehara T,
Takagi Y.
Study on frequency of prostate carcinoma and benign prostatic hypertrophy by mass screening in Hokkaido.
Jpn J Urol
1991; 83: 420–426 (in Japanese).
10.5980/jpnjurol1989.82.420 Google Scholar
- 22 Boyarsky S, Jones G, Paulson DF, Prout GR Jr. A new look at bladder neck obstruction by the Food and Drug Administration regulators: guidelines for investigation of benign prostatic hypertrophy. Trans Am Assoc Genitourin Surg 1977; 68: 29–32.
- 23
Madsen PO,
Iversen P.
A point system for selecting operative candidates. In: F Hinman, (ed)
Benign prostatic hypertrophy.
New York
: Springer-Verlag, 1983: 763–765.
10.1007/978-1-4612-5476-8_79 Google Scholar
- 24 Barry MJ, Fowler FJ JR, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK Cockett ATK, the Measurement Committee of the American Urological Association. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol 1992; 148: 1549–1557.
- 25 Cockett ATK, Aso Y, Denis L, Khoury S, Barry M, Carlton CE, Coffey D, Fitzpatric J, Griffiths K, Hald T, Holtgrewe L, Jardin A, McConnell J, Mebust W, Murphy G, Roehrborn C, Smith P, Steg A and the members of the committee. Recommendations of the International Consensus Committee concerning: 1. Prostate Symptom Score (I-PSS) and Quality of Life Assessment, 2. Diagnostic work-up of patients presenting with symptoms suggestive of prostatism, 3. Patients evaluation for research studies, and 4. BPH treatment. In: ATK Cockett, Y Aso, C Chatelan, L Denis, K Griffiths, S Khoury, GP Murphy, (eds) Proceedings of the first International Consultation on Benign Prostatic Hyperplasia. Paris : Scientific Communication International, 1991: 279–340.
- 26 Sagnier PP, Richard F, Botto H, Tellic P, Dreyfus J-P, Boyle P. Appendix B, Adaptation and cultural validation in French language of the International Prostate Symptom Score (I-PSS) and Quality of Life assessment. In: ATK Cockett, Y Aso, C Chatelaine, L Denies, K Girths, S Cheery, GP Murphy, (eds) Proceedings of the first International Consultation on Benign Prostatic Hyperplasia. Paris : Scientific Communication International, 1993: 144–147.
- 27 Tsukamoto T, Kumamoto Y, Masumori N, Miyake K, Rhodes T, Girman CJ, Guess HA, Jacobsen SJ, Lieber MM. Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J Urol 1995; 154: 391–395.
- 28 Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993; 150: 58–89.
- 29 Sagnier P-P, Girman CJ, Garraway M, Kumamoto Y, Lieber MM, Richard F, MacFarlane G, Guess HA, Jacobsen SJ, Tsukamoto T, Boyle P. International comparison of the community prevalence of symptoms of prostatism in four countries. Eur Urol 1996; 29: 15–20.
- 30 Homma Y, Kawabe K, Tsukamoto T, Yamanaka H, Okada K, Okajima E, Yoshida O, Kumazawa J, Gu, F-L, Lee C, Dela Cruz RC, Tantiwang A, Lim PHC, Sheikh M, Bapat SD, Tajima K, Aso Y. An epidemiological survey on benign prostatic hyperplasia in Asia using International Prostatic Symptom Score questionnaire. Int J Urol 1997; 4: 40–46.
- 31 Chung MK, Lee SD, Choi EH, Soe HK, Yoon JB. Prevalence of beging prostatic hyperplasia and prostatism in Korean men; a community-based study. The Third Asian Congress of Urology. Seoul, Korea. 1996: 61 (abstrbook).
- 32 Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991; 338: 469–471.
- 33
Guess HA.
The prevalence of benign prostatic hyperplasia in population surveys. In: WM Garraway, (ed)
Epidemiology of prostate diseases.
Berlin
: Springler-Verlag, 1995: 121–131.
10.1007/978-3-642-78826-0_11 Google Scholar
- 34 Sagnier P-P, McFarlane G, Richard F, Botto H, Teillac P, Boyle P. Results of an epidemiological survey using a modified American Urological Association Symptom Index for benign prostatic hyperplasia in France. J Urol 1994; 151: 1266–1270.
- 35 Norman RW, Nickel JC, Fish D, Pickett N. “Prostate-related symptoms” in Canadian men in 50 years of age or older: prevalence and relationships among symptoms. Br J Urol 1994; 74: 542–550.
- 36 Bosch JLHR, Hop WCJ, Kirkels WJ, Schroder FH. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual volume. Br J Urol 1995; 75: 622–630.
- 37 Hunter DJW, Berra-Unamuno A, Martina-Gordo A. Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old or older. J Urol 1996; 155: 1965–1970.
- 38 Guess HA, Chute CG, Garraway WM, Girman CJ, Panser LA, Lee RJ, Jacosen SJ, McKelvie GB, Oesterling JE, Lieber MM. Similar level of urologic symptoms have similar impact Scottish and American men-although Scots report less symptoms. Urology 1993; 150: 1701–1705.
- 39 Benign Prostatic Hyperplasia Guideline Panel. Benign prostatic hyperplasia: diagnosis and treatment. Rockville , Maryland : U.S. Department of Health and Human Services, 1994: AHCPR publication no–0582. (Clinical Practice Guideline; no 8.): 15–17.
- 40 Girman CJ, Panser LA, Epstein RS, Oesterling JE, Jacobsen SJ, Lieber MM, Guess HA. Natural history of prostatism: impact of urinary symptoms on quality of life in 2115 randomly selected community men. Urology 1994; 44: 825–831.
- 41 Masumori N, Kumamoto Y, Tsukamoto T, Itoh N, Koroku M, Tanaka Y. Changes in the voiding condition with aging in elderly males–results of a field survey for prostatic diseases. Jpn J Urol 1994; 1342–1347 (in Japanese).
- 42 Yachiku S. Clinical evaluation of the urofiowmetry. Acta Urol Jpn 1981; 27: 1019–1022 (in Japanese).
- 43 Kitagawa N, Ichikawa T, Akimoto S, Shimazaki J. Natural course of human benign prostatic hyperplasia with relation to urinary disturbance. Prostate 1994; 24: 279–284.
- 44 Diokno AC, Brown MB, Goldstein NG, Herzog R. Urinary flow rates and voiding pressures in elderly men living in a community. J Urol 1994; 151: 1550–1553.
- 45 Girman CJ, Panser LA, Chute CG, Oesterling JE, Barett DF, Chen CC, Arrighi HM, Guess HA, Lieber MM. Natural history of prostatism: urinary flow rates in a community-based study. J Urol 1993; 150: 887–892.
- 46 Masumori N, Tsukamoto T, Kumamoto Y, Miyake H, Rhodes T, Girman CJ, Guess HA, Jacobsen SJ, Lieber MM. Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community-based studies in 2 countries. J Urol 1996; 155: 1324–1327.
- 47 Kaplan SA, Te AE. Urofiowmetry and urodynamics. Urol Clin N Am 1995; 22: 309–320.
- 48 Swyer GIM. Post-natal growth changes in the human prostate. J Anat 1944; 78: 130–145.
- 49 Wada T, Ohishi Y, Tashiro K, Machida T, Furusato M, Masumoto I, Tokuda T, Aizawa S. Morphometric observation of the Japanese prostate obtained at autopsy. Jpn J Clin Urol 1985; 39: 1009–1012 (in Japanese).
- 50 Watanabe H. Natural history of benign prostatic hyperplasia. Ultrasound Med Biol 1986; 12: 567–571.
- 51 Bosch JLHR, Hop WCJ, Niemer QHJ, Bangma CH, Kirkels WJ, Schroder FH. Parameters of prostate volume and shape in a community based population of men 55 to 74 years old. J Urol 1994; 152: 1501–1505.
- 52 Masumori N, Tsukamoto T, Kumamoto Y, Miyake H, Rhodes T, Girman CJ, Guess HA, Jacobsen SJ, Lieber MM. Age-related differences in internal prostatic architecture on transrectal ultrasonography- results of a community-based survey in Japan. J Urol 1997; 157(5) (in press).
- 53 Watanabe H, Date S, Ohe H, Saitoh M, Tanaka S. A survey of 3,000 examinations by transrectal ultrasono-tomography. Prostate 1980; 1: 271–278.
- 54 Shida K. Annual Report of Prostate-Mass Screening (through 1994) by the Prostate Research Foundation, 1996.
- 55 Bosch JLHR, Hop WCJ, Kirkels WJ, Schroder FH. Natural history of benign prostatic hyperplasia: appropriate case definition as estimation of its prevalence in the community. Urology 1995; 46: 34–40.
- 56 Arrighi HM, Guess HA, Metter EJ, Fozard JL. Symptoms and signs of prostatism as risk factors for prostatectomy. Prostate 1990; 16: 253–261.
- 57 Jacobsen SJ, Girman CJ, Guess HA, Rhodes T, Oesterling JE, Lieber MM. Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men. J Urol 1996; 155: 595–600.
- 58 Garraway WM, Armstrong C, Auld S, King D, Simpson RJ. Follow-up of a cohort of men with un-treated benign prostatic hyperplasia. Eur Urol 1993; 24: 313–318.
- 59 Diokno AC, Brown MB, Goldstein N, Herzog AR. Epidemiology of bladder emptying symptoms in elderly men. J Urol 148; 1817–1821.
- 60
Clark R.
The prostate and endocrine: a control series.
Br J Urol
1937; 9: 254–271 (cited from reference 63).
10.1111/j.1464-410X.1937.tb06620.x Google Scholar
- 61 Crigen AA, Hickling JB, Saunders CRG, Carpenter RG. Natural history of prostatic obstruction. J R Coll Gen Pract 1969; 18: 226–232.
- 62 Birkoff JD, Weiderhorn AR, Hamilngton ML, Zinsser HH. Natural history of benign prostatic and acute urinary retention. Urology 1976; 7: 48–52.
- 63 Ball A, Feneley RC, Abrams PH. The natural history of untreated “Prostatism.” Br J Urol 1981; 53: 613–616.
- 64 Issacs JT. Importance of the natural history of benign prostatic hyperplasia in the evaluation of pharmacologic intervention. Prostate 1990; 17 (suppl 3): 1–7.
- 65 Meigs JB, Barry MJ. Natural history of benign prostatic hyperplasia. In: R Kirby, J McConnel, J Fitzpatrick, C Roehrborn, P Boyle, (eds) Textbook of Benign Prostatic Hyperplasia. Oxford : ISIS Medical Media, 1996: 125–135.
- 66 Barry MJ, Fowler FJ Jr, Bin L, Pitts JC III, Harris CJ, Mulley AG Jr. The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists. J Urol 1997; 157: 10–15.
- 67 Kawabe K, Ueno A, Takimoto Y, Aso Y, Kato H, Kitagawa R, Imamura K, Oshima H, Toma H, Tazaki H, Koiso K, Higashihara E, Homma Y, Saito I, Saiko Y, Yokoyama M, Fujito S, Takahashi S, Nito H, Suzuki A, Hara M, Fujita K, Kawamura T, Isobe H, Kawazoe K, Tanaka T, Kawachi Y, Iwata S, Yamaguchi K, Takasu H, Morizumi M, Higaki Y, Maruyama K, Ando M, Takagi K, Mizuno T, Wakui M, Sakai K, Nakazawa H, Goya N, Okumura T, Tomoe H, Tachibana M, Tago K, Nemoto R, Nakano M, Suzuki A, Nagae H, Kambayashi T, Hata M, Tsuruta A. Clinical evaluation of YM617 on bladder outlet obstruction associated with benign prostatic hypertrophy–a double-blind, multi-center study compared with placebo. Jpn J Urol Surg 1991; 4: 231–242 (in Japanese).
- 68 Kumamoto Y, Tsukamoto T, Yachiku S, Kaneko S, Tsichida S, Nishizawa S, Orokasa S, Chiba Y, Shimazaki J, Yasuda K, Aso Y, Homma Y, Koshiba K, Yokoyama E, Kawabe K, Kageyama S, Miyake K, Kondo A, Kurita T, Boku E, Miyagawa M, Nakamura I, Kumazawa J, Yamashita H, Osada Y, Kiutada S, Nakajima M. Clinical evaluation of terazosin hydrochloride on urinary obstruction caused by benign prostatic hypertrophy–double blind comparative study compared with placebo. Jpn J Urol Surg 1992; 5: 823–840 (in Japanese).
- 69 Aso Y, Akaza H, Kumamoto Y, Orokasa S, Yamanaka H, Koiso K, Shimazaki J, Tazaki H, Hosaka M, Yoshida O, Okuyama A, Kotake T, Ohmori H, Kumazawa J, Saito Y, Tsukamoto T, Imai K, Isaka S, Honma Y, Baba S, Usami M, Gunji A, Nishigaki M. Late phase II study of MK-906 in patients with benign prostatic hypertrophy–a dose finding study with double blind manner. Jpn J Urol Surg 1995; 8: 169–185 (in Japanese).
- 70 Roehrborn CG. The placebo effect in the treatment of benign prostatic hyperplasia. In: R Kirby, J McConnel, J Fitzpatrick, C Roehrborn, P Boyle, (eds) Textbook of benign prostatic hyperplasia. Oxford : ISIS Medical Media, 1996: 239–258.
- 71 Barham CP, Pocock RD, James ED. Who needs a prostatectomy?. Review of a waiting list. Br J Urol 1993; 72: 314–317.
- 72 Homma Y, Kawabe K, Tsukamoto T, Yamaguchi O, Okada K, Aso Y, Watanabe H, Okajima E, Kumazawa J, Yamaguchi T, Ohashi Y. Estimate criteria for efficacy of treatment in benign prostatic hyperplasia. Int J Urol 1996; 3: 267–273.
Citing Literature
